New Gumpus Medical Limited 12617209 false 2022-06-01 2023-05-31 2023-05-31 The principal activity of the company is the provision of medical services Digita Accounts Production Advanced 6.30.9574.0 true 12617209 2022-06-01 2023-05-31 12617209 2023-05-31 12617209 core:CurrentFinancialInstruments core:WithinOneYear 2023-05-31 12617209 bus:Micro-entities 2022-06-01 2023-05-31 12617209 bus:AuditExemptWithAccountantsReport 2022-06-01 2023-05-31 12617209 bus:FullAccounts 2022-06-01 2023-05-31 12617209 bus:SmallCompaniesRegimeForAccounts 2022-06-01 2023-05-31 12617209 bus:RegisteredOffice 2022-06-01 2023-05-31 12617209 bus:Director1 2022-06-01 2023-05-31 12617209 bus:Director2 2022-06-01 2023-05-31 12617209 bus:PrivateLimitedCompanyLtd 2022-06-01 2023-05-31 12617209 countries:EnglandWales 2022-06-01 2023-05-31 12617209 2021-06-01 2022-05-31 12617209 2022-05-31 12617209 core:CurrentFinancialInstruments core:WithinOneYear 2022-05-31 iso4217:GBP xbrli:pure

New Gumpus Medical Limited

Annual Report and Unaudited Financial Statements
Year Ended 31 May 2023

Registration number: 12617209

 

New Gumpus Medical Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Financial Statements

2

 

New Gumpus Medical Limited

Company Information

Directors

Dr B Scrace

Mrs E Scrace

Registered office

Lowin House
Tregolls Road
Truro
Cornwall
TR1 2NA

Accountants

PKF Francis Clark
Chartered Accountants
Lowin House
Tregolls Road
Truro
Cornwall
TR1 2NA

 

New Gumpus Medical Limited

Balance Sheet

31 May 2023

2023
£

2022
£

Fixed assets

34,217

39,945

Current assets

10,454

8,817

Prepayments and accrued income

1,641

2,158

Creditors: Amounts falling due within one year

(449)

(456)

Net current assets

11,646

10,519

Total assets less current liabilities

45,863

50,464

Accruals and deferred income

(1,300)

(1,300)

 

44,563

49,164

Capital and reserves

44,563

49,164

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Lowin House
Tregolls Road
Truro
Cornwall
TR1 2NA
United Kingdom

These financial statements were authorised for issue by the Board on 21 February 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2022 - 0).

 

New Gumpus Medical Limited

Balance Sheet

31 May 2023

For the financial year ending 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS105 The Financial Reporting Standard applicable to the Micro-entities Regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 21 February 2024 and signed on its behalf by:
 

.........................................
Dr B Scrace
Director

.........................................
Mrs E Scrace
Director

Company Registration Number: 12617209